Physician profile
Thomas C Crawford
NPI 1053430496
$21,056.45
in general payments reported to CMS, 2019-2025
10 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $141 · 2023: $1,442 · 2024: $5,556 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $5,764 · Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,222.14 |
| Travel and Lodging | $5,763.93 |
| Food and Beverage | $1,808.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $13,323.50 | 2023-2025 | Assure Wcd |
| Abbott Laboratories | $3,768.73 | 2023-2024 | Aveir |
| Medtronic, INC. | $1,634.86 | 2024 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Atricure, INC. | $1,470.54 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Boston Scientific Corporation | $296.56 | 2019-2025 | General - Therapies |
| Philips North America LLC | $251.51 | 2025 | Igt Devices Undivided, Lm Undivided |
| Impulse Dynamics (USA) INC. | $154.13 | 2025 | Optimizer |
| Medtronic Vascular, INC. | $126.90 | 2020 | |
| Cardiva Medical, INC. | $15.24 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.